Sakharov I Iu, Dukhanina E A, Danilov S M
Biokhimiia. 1986 Jun;51(6):946-51.
Using chromatofocusing, an angiotensin-converting enzyme (EC 3.4.15.1) has been isolated from human lung. The procedure allows for 24 300-fold purification of the enzyme. The enzyme specific activity is 36.3 u. per mg protein; Mr as determined by polyacrylamide gel electrophoresis is 150 000. The lung enzyme after solubilization by trypsin treatment was found to be heterogeneous. Four isoforms of the enzyme with pI 5.3, 4.9, 4.8 and 4.6 were identified. The pH-optimum for the enzyme with respect to hippuryl-L-histidyl-L-leucine hydrolysis lies at 8.3; Km = 2.8 mM. The effect of Cl- on the enzyme activity was studied. It was found that the bradykinin-potentiating factor (SQ 20 881) inhibits the human lung angiotensin-converting enzyme (I50 = 1.6 X 10(-8) M).
利用层析聚焦法,已从人肺中分离出一种血管紧张素转换酶(EC 3.4.15.1)。该方法可使该酶纯化24300倍。酶的比活性为每毫克蛋白质36.3单位;通过聚丙烯酰胺凝胶电泳测定的相对分子质量为150000。经胰蛋白酶处理溶解后的肺酶被发现具有异质性。鉴定出该酶的四种同工型,其等电点分别为5.3、4.9、4.8和4.6。该酶催化马尿酰-L-组氨酰-L-亮氨酸水解的最适pH值为8.3;米氏常数(Km)为2.8 mM。研究了氯离子对酶活性的影响。发现缓激肽增强因子(SQ 20881)可抑制人肺血管紧张素转换酶(半数抑制浓度I50 = 1.6×10−8 M)。